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Serum prolactin levels in diff erential 
diagnosis of pediatric epileptic and 
nonepileptic (pseudo-SEIZURES) seizures
Hatice Bülbül Çitilcioğlu1, Selçuk Matyar2, Okan Akgül1, İbrahim Hakan Bucak3, Mehmet Turgut3
The aim was to determine diagnostic value of serum prolactin levels in the diff erential diagnosis of epileptic and nonepileptic  seizures 
in children. The study included 100 patients aged one month to 18 years, admitted to the hospital for seizure complaints. All patients 
underwent electroencephalography in the postictal period and their serum prolactin levels were measured at 10 min and 60 min of 
the postictal period. The mean 10-min serum prolactin level was 37.1±20.09 ng/mL and 16±14.59 ng/mL (p<0.01) in patients with 
epileptic and nonepileptic seizures, respectively. After grouping of patients with nonepileptic seizures, the mean 10-min serum 
 prolactin level in patients with epileptic seizures and those with syncope was 37.1±20.09 ng/mL and 30.52±19.21 ng/mL (p>0.05), 
respectively. The mean 10-min prolactin level in patients with epileptic seizures and those with non-syncope epileptic seizures (night 
terror, conversion and breath holding spells) was 37.1±20.09 ng/mL and 10.9±5.95 ng/mL (p<0.01), respectively. In conclusion, 
 serum prolactin level in the postictal period is an important marker in the diff erential diagnosis of epileptic and nonepileptic seizures. 
There was no signifi cant diff erence between serum prolactin levels in the diff erential diagnosis of epileptic seizures and syncope, but 
it had an important role in diff erentiating nonepileptic cases such as breath holding spells, night terror and hysterical conversions 
from epileptic seizures and syncope.
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INTRODUCTION
Epileptic seizure (ES) is a clinical condition made up of tem-
porary symptoms and/or fi ndings due to abnormally exces-
sive and synchronized neuronal discharges in the brain (1). 
Epilepsy is a tendency of the brain to form epileptic seizures 
plus at least one epileptic seizure (2). Clinical and electro-
graphic classifi cations of epileptic seizures were issued by 
the International League against Epilepsy (ILAE) in 1981 and 
are still widely accepted throughout the world (3). We may 
encounter epilepsy in many clinical forms. The clinical prop-
erties, etiology, severity and prognosis of epilepsy with con-
comitant neurological fi ndings are highly variable. For this 
reason, the diff erential diagnosis of epilepsy and nonepilep-
tic seizures (NES) may be diffi  cult (4). The authors report that 
20%-25% of patients who are referred to epilepsy clinic do 
not really have epilepsy (5). Similarly, 10%-15% of children 
diagnosed with treatment-resistant epilepsy actually have 
nonepileptic attacks (6). The most common misdiagnoses 
include syncope (44%), psychiatric disorders (20%), breath 
holding spells (11%), migraine and night terror (12%), and 
other rare reasons (11%) (5).
Prolactin (PRL) is a polypeptide hormone secreted from the 
lactotrope cells of the anterior hypophysis and its secretion 
aff ects sleep, stress, surgical interventions and antiepileptic 
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medication (7,8). The increase in PRL levels following an ES 
has been known for approximately 40 years (9). It has also 
been proven that the type, localization and duration of the 
seizure aff ect PRL secretion (10). Video-electroencephalog-
raphy (video-EEG) is defi nitely the gold standard in the dif-
ferential diagnosis of ES and NES. However, it is not applica-
ble in emergency services. Although there are many studies 
evaluating PRL levels in the postictal period for the diff eren-
tial diagnosis of ES and NES, the studies done on children 
are limited.
In our study, it was aimed to measure serum PRL levels at 10 
and 60 min for the diff erential diagnosis of ES and NES in 
children aged one month to 18 years. 
PATIENTS AND METHODS
The study was carried out at the Adana Numune Education 
and Research Hospital, Adana, Turkey (ethical approval no. 
31032010/17). The study included 131 children aged one 
month to 18 years, referred to our Pediatrics and Emergency 
Policlinics, Adana Numune Research and Training Hospital, 
for seizure complaints. An informed consent was obtained 
from parents/guardians of all study participants. As the 
study was planned as a prospective one, 31 cases with liver 
and/or kidney dysfunction, electrolyte imbalance, fi ndings 
of intracranial infection, or a history of medication use other 
than antiepileptic medications were excluded.
The cases were divided into patient and control groups. Pa-
tient group included 50 patients (32 female and 18 male) 
admitted to our pediatrics and/or emergency units within 
10 minutes of seizure complaint and thought to have sus-
tained ES after detailed history and physical examination 
(group 1). Another 50 patients (29 female and 21 male) ad-
mitted to our pediatrics and/or emergency units within 10 
minutes of seizure complaint and thought to have had NES 
after detailed history and physical examination were includ-
ed in control group (group 2). Sleep EEG was performed in 
patients of both groups only once in the postictal period, 
approximately ten days after admission to the hospital.
Venous blood was drawn in all patients at postictal 10 min 
and 60 min using 5-mL vacuumed tubes without anticoag-
ulants. The samples were kept at room temperature for co-
agulation and centrifuged for 10 min at 3000 G. Sample PRL 
levels were measured on an ADVIA Centaur XP (Siemens 
Healthcare Diagnostics Inc., Tarrytown, USA), a fully auto-
mated immunoautoanalyzer with original Siemens kits us-
ing the chemiluminometric method. The reference range of 
serum PRL was 2.1-17.7 ng/mL (11). 
Statistical analysis
Statistical data analysis was done by use of the SPSS 15.00 
package program. Mann Whitney U test, used on compari-
son of two groups that did not show normal distribution, 
and Kruskal Wallis test was used on general comparison 
among more than two groups. Dual Mann Whitney U test 
was used for signifi cant fi ndings obtained on comparison of 
more than two groups, while Bonferroni-adjusted Mann 
Whitney U test was used on comparison of subgroups. 
Spearman rank correlation analysis was used to analyze cor-
relation between quantitative measurements. The level of 
signifi cance was set at p=0.05 in all tests. 
RESULTS 
The mean age of 50 patients in group 1 (epileptic seizure 
group, patient group) was 5.8±5.3 years; there were 32 
(64%) female and 18 (36%) male patients. The mean age of 
50 patients in group 2 (nonepileptic seizure group, control 
group) was 11±5.8 years; there were 29 (58%) female and 21 
(42%) male patients. The mean age was signifi cantly lower 
in the epileptic seizure group (p<0.001). There was no statis-
tically signifi cant between-group diff erence according to 
gender (p>0.05).
Twenty-three group 1 patients had been previously diag-
nosed with epilepsy and 21 of them had been using antie-
pileptic medications. The remaining 27 patients were newly 
diagnosed. When the groups were compared according to 
the duration of seizures, no signifi cant diff erence was found 
between the groups (p>0.05). The interictal EEGs of 38 pa-
tients were interpreted as pathological. EEGs were normal 
in all group 2 patients. In group 2, 15 (30%) patients were 
diagnosed with syncope, 20 (40%) with conversion, ten 
(20%) with breath holding spells, and fi ve (10%) with night 
terrors. Demographic and clinical characteristics of study 
patients are shown in Table 1.
When serum PRL levels were evaluated according to the 
postictal drawing time, the 10-min serum PRL levels were 
found to be statistically signifi cantly higher in group 1 as 
compared with group 2 (p<0.001), but there was no statisti-
cally signifi cant between-group diff erence in serum PRL 
levels at 60 min (p>0.05). The 10-min and 60-min serum PRL 
levels are shown in Table 2. 
DISCUSSION
Convulsions account for 1%-2% of admissions to emergency 
department (12). Video-EEG is the gold standard for diff eren-
tial diagnosis of epilepsy in clinical setting; however, it is ex-
pensive and usually not available (13). There is a known need 
of a parameter that can be used routinely to diff erentiate ES 
and NES. It has been reported that serum PRL levels, signifi -
cantly increasing after ES and not signifi cantly changing af-
ter NES except for syncope, could be used as an important 
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marker on diff erential diagnosis (13). The hypothesis of in-
creased PRL secretion during the ictal period is being de-
fended. In 1978, Trimble et al. were the fi rst to report in the 
literature that PRL levels were signifi cantly higher in patients 
with ES as compared with patients that had NES (9).
The studies of ES and NES in children and adolescents are 
highly limited. In our study, we found a statistically signifi -
cant age diff erence between the ES and NES groups. We 
believe that the age increase in the NES group may be due 
to conversions. The American Academy of Neurology sug-
gests evaluation of PRL levels in adults and older children to 
diff erentiate generalized tonic-clonic seizures or complex 
partial seizures from psychogenic NES at 10-20 min follow-
ing the attack and interpreting the results in favor of gener-
alized tonic-clonic or partial seizures in case of increased 
results (14). Yerby et al. (13) report that the postictal serum 
PRL levels used for diff erential diagnosis of ES and NES are 
not increased in nonepileptic cases in contrast to epileptic 
cases, and Luef (15) reports that the 15-20 min serum PRL 
increase may be helpful in diff erentiating between psycho-
genic and complex partial and generalized tonic-clonic sei-
zures but may not be of help in diff erentiating between 
epileptic seizure and syncope.
The results obtained in our study showed that serum PRL 
levels increased signifi cantly in epilepsies. Considering the 
diff erence and time diff erence between the groups, it was 
found that the 10-min serum PRL levels were higher in the 
epileptic group as compared with the nonepileptic group 
(p<0.001), but there was no signifi cant diff erence in the 60-
min serum PRL levels between the epileptic and nonepi-
leptic groups (p>0.05). Considering diff erence within the 
groups according to timing, the 10-min serum PRL levels 
were higher than the 60-min serum PRL levels; the diff er-
ence was statistically signifi cant (p<0.001). When syncope 
was compared between the nonepileptic group and other 
nonepileptic conditions (conversion, breath holding spell, 
night terror), it was found that the 10-min serum PRL levels 
were higher in syncope cases (p<0.01).
These results showed that serum PRL levels did not help dif-
ferentiate cases of syncope and epilepsies; however, simple 
TABLE 1. Demographic and clinical characteristics of study patients
Age (yrs)
Group 1 Group 2 P (<0.05)
5.83 ± 5.29 - 4.37 (0.17-17)* 11 ± 5.75 - 14,085 (1-17.5)* < 0.001
Gender n (%) Female 32 (64) 29 (58) > 0.05
Male 18 (36) 21 (42) > 0.05
Epileptic Seizures n (%) 50 (100) - NE
Generalised seizures 43 (86) - NE
Status epilepticus 7 (14) - NE
Non-Epileptic Seizures n (%) - 50 (100) NE
Syncope - 15 (30) NE
Conversion - 20 (40) NE
Breath holding spells - 10 (20) NE
Night terror - 5 (10) NE
Duration of seizure (min) 8.12 ± 11.28, 3.50 (1-60)* 7.0 ± 9.9, 3.0 (1-60)* > 0.05
EEG Findings n (%) Abnormal 38 (76) 0 NE
Normal 12 (24) 50 (100) < 0.001
TABLE 2. Comparison of serum prolactin levels between the groups according to blood sampling timing
Prolactin (ng/ml)
Mean ± standard deviation, median (min.-max.)
10. minute p 60. minute P
Group 1 37.1 ± 20.09, 30 (12 -96)
<0.001
12.66 ± 7.01, 11.8 (1.9-7.7)
> 0.05
Group 2 16 ± 14.59, 13.35 (1.7 - 88) 9.12 ± 4.28, 10.0 (2.1-15)
Group 1 37.1 ± 20.09, 30 (12 - 96)
> 0.05
12.66 ± 7.01, 11.8 (1.9-7.7)
> 0.05
Group 2 (Syncope) 30.52 ± 19.21, 25.3 (19.6-88) 11.9 ± 2.29, 11.5 (9.6-15)
Group 1 37.1 ± 20.09, 30 (12 - 96)
<0.001
12.66 ±7.01, 11.8 (1.9-27.7)
> 0.05Group 2 Conversion Breath Holding 
Spell Night Terror
10.9 ± 5.95, 8.5 (1.7-29) 7.72 ± 4.45, 9.6 (2.1-14)
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laboratory tests can diff erentiate syncope from other non-
epileptic cases (conversion, breath holding spell, night ter-
ror). These results are consistent with those described in the 
literature. Again consistent with other studies, our results 
showed that serum PRL levels did not help diff erentiate 
epilepsies and syncopes. In these studies, Oribe et al. (16) 
showed that serum PRL levels were as high as those seen in 
epilepsies in 21 patients in whom they induced syncopes 
with tilt test. Leuf (15) showed that PRL was not helpful in 
diff erentiation of epileptic seizure and syncope; and fi nally 
Chen et al. (14) showed that serum PRL levels were not help-
ful in diff erentiating epileptic seizure and syncope. Based on 
the data recorded in our study, we determined that the 
time of measurement was the only factor aff ecting PRL lev-
el, and not any other factor (gender, EEG pathology, antie-
pileptic drug use, duration of seizures, etc.). Therefore, we 
believe that blood sample should be obtained from pa-
tients who are admitted to emergency policlinics with sei-
zures (epileptic or nonepileptic) in the postictal period as 
soon as possible in order to evaluate PRL levels. Although 
we did not use PRL levels simultaneously with video-EEGs, 
we believe that PRL measurement is just as or even more 
important than video-EEGs in diff erentiation of ES from NES 
thanks to its accessibility where a laboratory is available. A 
limitation of this study was the fact that complex partial sei-
zures were not taken as a separate group.
To conclude, serum PRL levels were found to be higher in 
the epileptic group and in syncope, which is a nonepileptic 
case, which is consistent with literature reports. We suggest 
that PRL levels be used to diff erentiate ES and NES in young 
children. We also determined that blood samples to be 
used for diff erential diagnosis should be obtained as soon 
as possible due to the fact that PRL reaches its peak at 10 
min and regresses back to its baseline between 60 and 90 
min. Extensive series of studies should be done to research 
the marker properties of serum PRL levels for the diff erential 
diagnosis of ES and NES in pediatric patients; timing of se-
rum PRL measurement should be standardized; and simul-
taneous evaluation of serum PRL levels with video-EEGs will 
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S A Ž E T A K
Serumske razine prolaktina u diferencijalnoj dijagnostici 
pedijatrijskih epileptičnih i neepileptičnih 
(pseudo-)napadaja
H. B. Çitilcioğlu, S. Matyar, O. Akgül, İ. H. Bucak, M. Turgut
Cilj ovoga ispitivanja bio je utvrditi dijagnostičku vrijednost serumskih razina prolaktina u diferencijalnoj dijagnostici epileptičnih i 
neepileptičnih napadaja u djece. U ispitivanje je bilo uključeno 100 djece u dobi od jednog mjeseca do 18 godina, primljenih u bol-
nicu zbog konvulzija. U svih bolesnika učinjena je elektroencefalografi ja u postiktalnom razdoblju, dok su njihove serumske razi-
ne prolaktina mjerene u 10. i 60. minuti postiktalnog razdoblja. Srednja 10-minutna razina prolaktina u serumu bila je 37,1±20,09 
ng/mL i 16±14,59 ng/mL (p<0,01) u bolesnika s epileptičnim odnosno neepileptičnim napadajima. Nakon grupiranja bolesnika s 
neepileptičnim napadajima 10-minutna srednja serumska razina prolaktina u bolesnika s epileptičnim napadajima i onih sa sinko-
pom bila je 37,1±20,09 ng/mL odnosno 30,52±19,21 ng/mL (p>0,05). U bolesnika s epileptičnim napadajima i onih s ne-sinkopnim 
epileptičnim napadajima (noćne more, konverzija i epizode zadržavanja daha) srednja 10-minutna razina prolaktina bila je 
37,1±20,09 ng/mL odnosno 10,9±5,95 ng/mL (p<0,01). Zaključuje se kako je serumska razina prolaktina u postiktalnom razdoblju 
važan biljeg u diferencijalnoj dijagnostici epileptičnih i neepileptičnih napadaja. Nije bilo značajne razlike među serumskim razina-
ma prolaktina u diferencijalnoj dijagnostici epileptičnih napadaja i sinkope, ali je ta razina imala važnu ulogu u razlikovanju 
neepileptičnih slučajeva kao što su epizode zadržavanja daha, noćne more i histerične konverzije od epileptičnih napadaja i sinkope.
Ključne riječi: prolaktin; epilepsija; epilepsija, post-traumatska; sinkopa
